Onset features and subsequent clinical evolution of childhood diabetes over several years

Pediatric Diabetes

Volumn 12, Issue 4 PART 1, 2011, Pages 326-334

  Lipton, Rebecca B ^a   Drum, Melinda L ^a   Danielson, Kirstie K ^a   Greeley, Siri Aw ^a   Bell, Graeme I ^a   Hagopian, William A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Beta cell function; Children and adolescents; Diagnosis; Epidemiology; Longitudinal study; Mixed diabetes phenotype; Natural history; Onset signs and symptoms; T1DM; T2DM

Indexed keywords

AUTOANTIBODY; C PEPTIDE;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; CHILD; CHILDHOOD DISEASE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE COURSE; ETHNICITY; FEMALE; HUMAN; HYPERGLYCEMIA; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AUTOANTIBODIES; C-PEPTIDE; CHICAGO; CHILD; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN-SECRETING CELLS; LONGITUDINAL STUDIES; MALE; OBESITY; PHENOTYPE;

EID: 79957445407     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00706.x     Document Type: Article

References (22)

1. Gortmaker S, Sappenfield W. Chronic childhood disorders: prevalence and impact. Pediatr Clin North Am 1984: 31: 3-18.
2. Smith TLS, Drum ML, Lipton RB. Incidence of childhood type 1 and non-type 1 diabetes in a diverse population: The Chicago Childhood Diabetes Registry, 1994 to 2003. J Pediatr Endocrinol Metab 2007: 20: 1093-1107.
3. Urakami T, Kubota S, Nitadori Y, Harada K, Owada M, Kitagawa T. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diab Care 2005: 28: 1876-1881.
4. The Diamond Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabetic Med 2006: 23: 857-866. DiaMond website.
5. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diab Care 2003: 26: 2876-2882.
6. Centers for Disease Control and Prevention. Defining Overweight and Obesity 2006 (available from
7. Ostchega Y, Prineas RJ, Paulose-Ram R, Grim CM, Willard G, Collins D. National Health and Nutrition Examination Survey 1999-2000: effect of observer training and protocol standardization on reducing blood pressure measurement error. J Clin Epidemiol 2003: 56: 768-774.
8. Lohman TG, Roche AF, Martorell R, eds. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books, 1988: 3-5, 7-8, 45-46.
9. Cobbaert C, Boerma GJ, Lindemans J. Evaluation of the Cholestech L.D.X. desktop analyser for cholesterol, HDL-cholesterol, and triacylglycerols in heparinized venous blood. Eur J Clin Chem Clin Biochem 1994: 32: 391-394.
10. Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diab Care 1999: 22: 1785-1789.
11. Blood Pressure: ; Cholesterol, HDL: ; Waist circumference.
12. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diab Care 1994: 17: 1281-1289.
13. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006: 108: 477-481.
14. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diab Care 1999: 22: 1655-1659.
15. Woo W, LaGasse JM, Zhou Z et al. A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies. J Immunol Methods 2000: 244: 91-103.
16. Faber OK, Binder C, Markussen J et al. Characterization of seven C-peptide antisera. Diabetes 1978: 27 (Suppl. 1): 170-177.
17. Berger B, Stenström G, Sundkvist G. Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest 2000: 60: 687-693.
18. Törn C, Landin-Olsson M, Lernmark A et al. Prognostic factors for the course of beta cell function in autoimmune diabetes. J Clin Endocrinol Metab 2000: 85: 4619-4623.
19. Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK, The Childhood Diabetes in Finland Study Group. Obesity, increased linear growth, and risk of type 1 diabetes in children. Diab Care 2000: 23: 1755-1760.
20. Wilkin TJ. For debate - the accelerator hypothesis: weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia 2001: 44: 914-922.
21. Cleary PA, Orchard TJ, Genuth S et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes. Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC) Study. Diabetes 2006: 55: 3556-3565.
22. Estrada CL, Danielson KK, Drum ML, Lipton RB. Hospitalization subsequent to diagnosis in young patients with diabetes in Chicago. Pediatrics 2009: 124: 926-934; PMID: 19706582.